|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-2-1
|
|
pubmed:abstractText |
This Phase I clinical trial was developed to assess the feasibility of combining high-dose intraarterial cisplatin chemotherapy with concurrent, concomitant boost accelerated radiation therapy for patients with previously untreated T4 and select patients with T3N0-N3M0 squamous cell carcinoma of the upper aerodigestive tract.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2004 American Cancer Society
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
559-68
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:15597408-Adult,
pubmed-meshheading:15597408-Aged,
pubmed-meshheading:15597408-Antineoplastic Agents,
pubmed-meshheading:15597408-Carcinoma, Squamous Cell,
pubmed-meshheading:15597408-Chemotherapy, Adjuvant,
pubmed-meshheading:15597408-Cisplatin,
pubmed-meshheading:15597408-Dose Fractionation,
pubmed-meshheading:15597408-Drug Administration Schedule,
pubmed-meshheading:15597408-Feasibility Studies,
pubmed-meshheading:15597408-Female,
pubmed-meshheading:15597408-Head and Neck Neoplasms,
pubmed-meshheading:15597408-Humans,
pubmed-meshheading:15597408-Infusions, Intra-Arterial,
pubmed-meshheading:15597408-Male,
pubmed-meshheading:15597408-Middle Aged,
pubmed-meshheading:15597408-Neoplasm Staging,
pubmed-meshheading:15597408-Pilot Projects,
pubmed-meshheading:15597408-Prospective Studies,
pubmed-meshheading:15597408-Radiotherapy, Adjuvant,
pubmed-meshheading:15597408-Survival Analysis,
pubmed-meshheading:15597408-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0-N3M0 squamous cell carcinoma of the upper aerodigestive tract.
|
|
pubmed:affiliation |
Division of Radiation Oncology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Clinical Trial, Phase I
|
